Minimizing the risk of sarcopenic obesity during androgen deprivation therapy-promising results for men treated with GnRH antagonists

Prostate Cancer Prostatic Dis. 2021 Sep;24(3):589-590. doi: 10.1038/s41391-021-00357-w. Epub 2021 Apr 5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Humans
  • Male
  • Obesity / chemically induced
  • Obesity / drug therapy*
  • Obesity / pathology
  • Prognosis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Sarcopenia / chemically induced
  • Sarcopenia / drug therapy*
  • Sarcopenia / pathology

Substances

  • Androgen Antagonists
  • Gonadotropin-Releasing Hormone